🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are urged to contact these accounts privately for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting products of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and customer laws, risking penalties, legal action or imprisonment.

Service Reaction and Material Elimination

Based on the social media company, the platform has taken down problematic material and prohibited associated hashtags and query recommendations. The company said it was dedicated to keeping the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Research also found groups with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.

After minutes of joining one community, a seller posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Product Information and Pricing

Within these groups, posts show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is valid, these digital products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly significant health risks”.